The DOI matches its Crossref record; 635 of the 635 references it cites were found in a registry or an index.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Open accessAbstract
of authors shown on this cover page is limited to 10 maximum.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of low EF, particularly in asymptomatic patients, is critical in reducing lifetime risk of mobility and mortality.[15][16][17]”
From Clinician Adoption of an Artificial Intelligence Algorithm to Detect Left Ventricular Systolic Dysfunction in Primary Care. (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Echocardiograms are considered the test of choice for the definitive diagnosis of left ventricular dysfunction.16”
From Clinician Adoption of an Artificial Intelligence Algorithm to Detect Left Ventricular Systolic Dysfunction in Primary Care. (2022) · cites this paper as [16]
In the citing paper
“Natriuretic peptide levels are part of the diagnostic assessment of HFpEF, 222 although natriuretic peptide levels are elevated in AF patients and the optimum diagnostic cut-off is still unknown.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [222]
In the citing paper
“as diltiazem and verapamil can have negative inotropic effects in patients with LVEF < 40%.222,534,535”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [222]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Self-citationEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lang, R. M., Badano, L. P., Mor‐Avi, V., Afilalo, J., Armstrong, A. D. C., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev014 · Cited by 8,583
Self-citation
Research works printed but not linked: 22
- McMurray, 2010, Clinical practice, Systolic heart failure. N Engl J Med, 3623, 228
- Killip, 1967, Treatment of myocardial infarction in a coronary care unit, A two year experience with 250 patients. Am J Cardiol, 20, 457
- Bleumink, 2004, Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study, Eur Heart J England;, 25, 1614, 10.1016/j.ehj.2004.06.038 · DOI
- Fuat, 2006, The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure, Br J Gen Pract, 56, 327
- Roma-Rodrigues, 2014, Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy, Appl Clin Genet, 7, 195
- Beckett, 2008, Treatment of hypertension in patients 80 years of age or older, N Engl J Med, 358, 1887, 10.1056/NEJMoa0801369 · DOI · Paper page
- Sciarretta, 2011, Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk, Arch Intern Med, 171, 384, 10.1001/archinternmed.2010.427 · DOI
- Faris, 2012, Diuretics for heart failure, Cochrane Database Syst Rev, 2, CD003838
- Cohn, 1997, Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III, Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation, 96, 856
- Cintra, 2014, Sleep apnea and nocturnal cardiac arrhythmia: a populational study, Arq Bras Cardiol, 103, 368
- Lafuente-Lafuente, 2012, Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation, Cochrane Database Syst Rev, 5, CD005049
- MacDonald, 2010, Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K, General Practice Research Database. Diabetes Care, 33, 1213
- Mahoney, 2005, Emergency interventions for hyperkalaemia, Cochrane Database Syst Rev, 2, CD003235
- Packer, 1996, The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 334, 1349, 10.1056/NEJM199605233342101 · DOI · Paper page
- Biegus, 2012, Liver function tests in patients with acute heart failure, Pol Arch Med Wewnętrznej, 122, 471, 10.20452/pamw.1413 · DOI
- Gray, 2009, A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial, Health Technol Assess, 13, 1, 10.3310/hta13330 · DOI
- Vital, 2013, Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema, Cochrane Database Syst Rev, 5, CD005351
- Wakai, 2013, Nitrates for acute heart failure syndromes, Cochrane Database Syst Rev, 8, CD005151
- Monsieurs, 2015, European Resuscitation Council Guidelines for Resuscitation 2015: Section 1, Executive summary. Resuscitation, 95, 1
- Schmidt, 2015, Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score, Eur Heart J, 36, 1, 10.1093/eurheartj/ehv194 · DOI
- Taylor, 2014, Exercise-based rehabilitation for heart failure, Cochrane Database Syst Rev, 4, CD003331
- McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810
Cited by
Sorted by citations
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citation2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationIbanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Self-citation2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationDapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab395 · Cited by 5,685
Self-citationCollet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Self-citationYancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109
Self-citationWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
Self-citation2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Self-citationDefibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Heerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M., & Cherney, D. Z. I. (2016) · Circulation · doi:10.1161/circulationaha.116.021887 · Cited by 1,376
Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, P., Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab777 · Cited by 1,317
Self-citationAngiotensin-neprilysin inhibition in acute decompensated heart failure
Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., Rocha, R., & Braunwald, E. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812851 · Cited by 1,260
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction
Shah, K. S., Xu, H., Matsouaka, R. A., Bhatt, D. L., Heidenreich, P. A., Hernandez, A. F., Devore, A. D., Yancy, C. W., & Fonarow, G. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.074 · Cited by 1,110
Self-citationPasricha, S.-R., Tye-Din, J., Muckenthaler, M. U., & Swinkels, D. W. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32594-0 · Cited by 1,069
Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031
Self-citationAmbrosetti, M., Abreu, A., Corrà, U., Davos, C. H., Hansen, D., Frederix, I., Iliou, M. C., Pedretti, R. F. E., Schmid, J.-P., Vigorito, C., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1177/2047487320913379 · Cited by 965
Self-citationDilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
Heart failure and kidney dysfunction: epidemiology, mechanisms and management
Schefold, J. C., Filippatos, G., Hasenfuss, G., Anker, S. D., & von Haehling, S. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.113 · Cited by 671
Self-citationEvaluation and management of heart failure with preserved ejection fraction
Borlaug, B. A. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0363-2 · Cited by 675
Shah, S. J., Lam, C. S. P., Svedlund, S., Saraste, A., Hage, C., Tan, R.-S., Beussink-Nelson, L., Ljung Faxén, U., Fermer, M. L., Broberg, M. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy531 · Cited by 656
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, R., Kolkhof, P., Bakris, G., Bauersachs, J., Haller, H., Wada, T., & Zannad, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa736 · Cited by 638
Self-citationEffect of dapagliflozin on heart failure and mortality in type 2 diabetes mellitus
Kato, E. T., Silverman, M. G., Mosenzon, O., Zelniker, T. A., Cahn, A., Furtado, R. H. M., Kuder, J., Murphy, S. A., Bhatt, D. L., Leiter, L. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040130 · Cited by 557
Obokata, M., Kane, G. C., Reddy, Y. N. V., Olson, T. P., Melenovsky, V., & Borlaug, B. A. (2017) · Circulation · doi:10.1161/circulationaha.116.024822 · Cited by 559
Self-citationSacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
Solomon, S. D., Vaduganathan, M., L. Claggett, B., Packer, M., Zile, M., Swedberg, K., Rouleau, J., A. Pfeffer, M., Desai, A., H. Lund, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044586 · Cited by 551
Self-citationClase, C. M., Carrero, J.-J., Ellison, D. H., Grams, M. E., Hemmelgarn, B. R., Jardine, M. J., Kovesdy, C. P., Kline, G. A., Lindner, G., Obrador, G. T., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.09.018 · Cited by 498
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502
High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction
Ellingsen, Ø., Halle, M., Conraads, V., Støylen, A., Dalen, H., Delagardelle, C., Larsen, A.-I., Hole, T., Mezzani, A., Van Craenenbroeck, E. M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.022924 · Cited by 414
Maximising the impact of patient reported outcome assessment for patients and society
Calvert, M., Kyte, D., Price, G., Valderas, J. M., & Hjollund, N. H. (2019) · BMJ · doi:10.1136/bmj.k5267 · Cited by 328
Grune, J., Beyhoff, N., Smeir, E., Chudek, R., Blumrich, A., Ban, Z., Brix, S., Betz, I. R., Schupp, M., Foryst-Ludwig, A., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10360 · Cited by 292
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Hahn, V. S., Knutsdottir, H., Luo, X., Bedi, K., Margulies, K. B., Haldar, S. M., Stolina, M., Yin, J., Khakoo, A. Y., Vaishnav, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050498 · Cited by 291
Grote Beverborg, N., Klip, I. T., Meijers, W. C., Voors, A. A., Vegter, E. L., van der Wal, H. H., Swinkels, D. W., van Pelt, J., Mulder, A. B., Bulstra, S. K., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004519 · Cited by 278
Self-citationRossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.013 · Cited by 274
Scherrenberg, M., Wilhelm, M., Hansen, D., Völler, H., Cornelissen, V., Frederix, I., Kemps, H., & Dendale, P. (2021) · European Journal of Preventive Cardiology · doi:10.1177/2047487320939671 · Cited by 251
Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-2904 · Cited by 248
Burnett, H., Earley, A., Voors, A. A., Senni, M., McMurray, J. J. V., Deschaseaux, C., & Cope, S. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003529 · Cited by 238
Self-citationCardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
Zelniker, T. A., & Braunwald, E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.040 · Cited by 236
Fanaroff, A. C., Califf, R. M., Windecker, S., Smith, S. C., & Lopes, R. D. (2019) · JAMA · doi:10.1001/jama.2019.1122 · Cited by 228
Self-citationWithaar, C., Meems, L. M. G., Markousis-Mavrogenis, G., Boogerd, C. J., Silljé, H. H. W., Schouten, E. M., Dokter, M. M., Voors, A. A., Westenbrink, B. D., Lam, C. S. P., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa256 · Cited by 223
Abraham, W. T., Lindenfeld, J., Ponikowski, P., Agostoni, P., Butler, J., Desai, A. S., Filippatos, G., Gniot, J., Fu, M., Gullestad, L., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa943 · Cited by 217
Self-citationGevaert, A. B., Shakeri, H., Leloup, A. J., Van Hove, C. E., De Meyer, G. R. Y., Vrints, C. J., Lemmens, K., & Van Craenenbroeck, E. M. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003806 · Cited by 211
Florkowski, C., Don-Wauchope, A., Gimenez, N., Rodriguez-Capote, K., Wils, J., & Zemlin, A. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1399336 · Cited by 189
Arnold, S. V., Inzucchi, S. E., Tang, F., McGuire, D. K., Mehta, S. N., Maddox, T. M., Goyal, A., Sperling, L. S., Einhorn, D., Wong, N. D., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317729252 · Cited by 144
Li, F., Xin, H., Zhang, J., Fu, M., Zhou, J., & Lian, Z. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044779 · Cited by 128
Withaar, C., Lam, C. S. P., Schiattarella, G. G., de Boer, R. A., & Meems, L. M. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab389 · Cited by 150
Serenelli, M., Böhm, M., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa496 · Cited by 138
Self-citationUnderstanding heart failure; explaining telehealth—a hermeneutic systematic review
Greenhalgh, T., A’Court, C., & Shaw, S. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0594-2 · Cited by 141
Xia, M.-F., Chen, L.-Y., Wu, L., Ma, H., Li, X.-M., Li, Q., Aleteng, Q., Hu, Y., He, W.-Y., Gao, J., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.003 · Cited by 133
Buck, H. G., Stromberg, A., Chung, M. L., Donovan, K. A., Harkness, K., Howard, A. M., Kato, N., Polo, R., & Evangelista, L. S. (2018) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.10.007 · Cited by 135
Skeletal muscle wasting in chronic heart failure
Suzuki, T., Palus, S., & Springer, J. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12387 · Cited by 134
Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation
Gómez-Ramírez, S., Brilli, E., Tarantino, G., & Muñoz, M. (2018) · Pharmaceuticals · doi:10.3390/ph11040097 · Cited by 132
Beldhuis, I. E., Streng, K. W., Ter Maaten, J. M., Voors, A. A., van der Meer, P., Rossignol, P., McMurray, J. J. V., & Damman, K. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003588 · Cited by 126
Self-citationKanagala, P., Cheng, A. S. H., Singh, A., Khan, J. N., Gulsin, G. S., Patel, P., Gupta, P., Arnold, J. R., Squire, I. B., Ng, L. L., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.11.031 · Cited by 126
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure
Costanzo, M. R., Ronco, C., Abraham, W. T., Agostoni, P., Barasch, J., Fonarow, G. C., Gottlieb, S. S., Jaski, B. E., Kazory, A., Levin, A. P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.528 · Cited by 125
Self-citationShahim, B., De Bacquer, D., De Backer, G., Gyberg, V., Kotseva, K., Mellbin, L., Schnell, O., Tuomilehto, J., Wood, D., & Rydén, L. (2017) · Diabetes Care · doi:10.2337/dc17-0245 · Cited by 114
Roy, C., Slimani, A., de Meester, C., Amzulescu, M., Pasquet, A., Vancraeynest, D., Beauloye, C., Vanoverschelde, J.-L., Gerber, B. L., & Pouleur, A.-C. (2018) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-018-0477-4 · Cited by 109
The role of diet and nutrition in heart failure: A state-of-the-art narrative review
Billingsley, H. E., Hummel, S. L., & Carbone, S. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.08.004 · Cited by 106
Cardiotoxicity of Anticancer Therapeutics
Dong, J., & Chen, H. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00009 · Cited by 95
Halabi, A., Sen, J., Huynh, Q., & Marwick, T. H. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01100-w · Cited by 93
Jensen, M. T., Treskes, R. W., Caiani, E. G., Casado-Arroyo, R., Cowie, M. R., Dilaveris, P., Duncker, D., Di Rienzo, M., Frederix, I., De Groot, N., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab011 · Cited by 93
Self-citationThe Hippo Signaling Pathway in Drug Resistance in Cancer
Zeng, R., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13020318 · Cited by 89
The role of wearables in heart failure
Singhal, A., & Cowie, M. R. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-020-00467-x · Cited by 85
Mizukawa, M., Moriyama, M., Yamamoto, H., Rahman, M. M., Naka, M., Kitagawa, T., Kobayashi, S., Oda, N., Yasunobu, Y., Tomiyama, M., et al. (2019) · International Heart Journal · doi:10.1536/ihj.19-313 · Cited by 87
Sarzani, R., Giulietti, F., Di Pentima, C., Giordano, P., & Spannella, F. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00189.2020 · Cited by 86
Bibliometric analysis on the Progress of chronic heart failure
Wang, H., Shi, J., Shi, S., Bo, R., Zhang, X., & Hu, Y. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101213 · Cited by 84
Puyol-Antón, E., Ruijsink, B., Mariscal Harana, J., Piechnik, S. K., Neubauer, S., Petersen, S. E., Razavi, R., Chowienczyk, P., & King, A. P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.859310 · Cited by 85
Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure
Kurz*†, K., Lanser†, L., Seifert, M., Kocher, F., Pölzl, G., & Weiss*, G. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12755 · Cited by 77
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J. V., Wikstrand, J., Anker, S. D., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.059 · Cited by 71
Self-citationSalvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules · doi:10.3390/biom12020176 · Cited by 62
Werhahn, S. M., Dathe, H., Rottmann, T., Franke, T., Vahdat, D., Hasenfuß, G., & Seidler, T. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12425 · Cited by 59
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain
Dini, L., Del Lungo, M., Resta, F., Melchiorre, M., Spinelli, V., Di Cesare Mannelli, L., Ghelardini, C., Laurino, A., Sartiani, L., Coppini, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01252 · Cited by 55
Pavlovic, N. V., GILOTRA, N. A., LEE, C. S., NDUMELE, C., MAMMOS, D., DENNISONHIMMELFARB, C., & AbshireSaylor, M. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.005 · Cited by 58
Aamodt, I. T., Lycholip, E., Celutkiene, J., Strömberg, A., Atar, D., Falk, R. S., von Lueder, T., Hellesø, R., Jaarsma, T., & Lie, I. (2019) · Journal of Medical Internet Research · doi:10.2196/10362 · Cited by 49
Self-citationBielecka-Dabrowa, A., Bytyçi, I., Von Haehling, S., Anker, S., Jozwiak, J., Rysz, J., Hernandez, A. V., Bajraktari, G., Mikhalidis, D. P., & Banach, M. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1135-z · Cited by 57
Self-citationHolt, A., Bjerre, J., Zareini, B., Koch, H., Tønnesen, P., Gislason, G. H., Nielsen, O. W., Schou, M., & Lamberts, M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008684 · Cited by 54
Elsanhoury, A., Nelki, V., Kelle, S., Van Linthout, S., & Tschöpe, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.720690 · Cited by 51
Sharma, S., Fox, H., Aguilar, F., Mukhtar, U., Willes, L., Bozorgnia, B., Bitter, T., & Oldenburg, O. (2019) · Sleep · doi:10.1093/sleep/zsz100 · Cited by 47
Evangelista, L. S., Jose, M. M., Sallam, H., Serag, H., Golovko, G., Khanipov, K., Hamilton, M. A., & Fonarow, G. C. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13213 · Cited by 48
The lived experience of caregivers of persons with heart failure: A phenomenological study
Petruzzo, A., Paturzo, M., Naletto, M., Cohen, M. Z., Alvaro, R., & Vellone, E. (2017) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117707666 · Cited by 46
Pathophysiology of Heart Failure with Preserved Ejection Fraction
Youn, J.-C., Ahn, Y., & Jung, H. O. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.02.001 · Cited by 45
Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy
Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1402 · Cited by 44
Self-citationWolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S. P., van Veldhuisen, D. J., Ponikowski, P., et al. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.01.006 · Cited by 43
Self-citationGorenek, B., Boriani, G., Dan, G.-A., Fauchier, L., Fenelon, G., Huang, H., Kudaiberdieva, G., Lip, G. Y. H., Mahajan, R., Potpara, T., et al. (2018) · EP Europace · doi:10.1093/europace/euy051 · Cited by 43
Self-citationNorman, J., Fu, M., Ekman, I., Björck, L., & Falk, K. (2018) · European Journal of Cardiovascular Nursing · doi:10.1177/1474515117715843 · Cited by 36
Pascual-Figal, D., Wachter, R., Senni, M., Bao, W., Noè, A., Schwende, H., Butylin, D., Prescott, M. F., Gniot, J., Mozheiko, M., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2020.05.012 · Cited by 38
Self-citationLarburu, N., Artetxe, A., Escolar, V., Lozano, A., & Kerexeta, J. (2018) · Mobile Information Systems · doi:10.1155/2018/1546210 · Cited by 35
Fitchett, D., Inzucchi, S. E., Wanner, C., Mattheus, M., George, J. T., Vedin, O., Zinman, B., & Johansen, O. E. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz621 · Cited by 34
Rushlow, D. R., Croghan, I. T., Inselman, J. W., Thacher, T. D., Friedman, P. A., Yao, X., Pellikka, P. A., Lopez-Jimenez, F., Bernard, M. E., Barry, B. A., et al. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.04.008 · Cited by 33
Harrington, J. L., de Albuquerque Rocha, N., Patel, K. V., Verma, S., & McGuire, D. K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1035-z · Cited by 32
Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology
Garnham, J. O., Roberts, L. D., Espino‐Gonzalez, E., Whitehead, A., Swoboda, P. P., Koshy, A., Gierula, J., Paton, M. F., Cubbon, R. M., Kearney, M. T., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12515 · Cited by 32
Tyl, B., Lopez Sendon, J., Borer, J. S., Lopez De Sa, E., Lerebours, G., Varin, C., De Montigny, A., Pannaux, M., & Komajda, M. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006720 · Cited by 29
Heider, K., Arzt, M., Lerzer, C., Kolb, L., Pfeifer, M., Maier, L. S., Gfüllner, F., & Malfertheiner, M. V. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1203-9 · Cited by 26
Symptom Diary Use and Improved Survival for Patients With Heart Failure
Park, L. G., Dracup, K., Whooley, M. A., McCulloch, C., Jin, C., Moser, D. K., Clark, R. A., Pelter, M. M., Biddle, M., & Howie Esquivel, J. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003874 · Cited by 27
Fauchier, L., Boriani, G., de Groot, J. R., Kreutz, R., Rossing, P., & Camm, A. J. (2021) · EP Europace · doi:10.1093/europace/euab184 · Cited by 22
Bouabdallaoui, N., O'Meara, E., Bernier, V., Komajda, M., Swedberg, K., Tavazzi, L., Borer, J. S., Bohm, M., Ford, I., & Tardif, J.-C. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12513 · Cited by 21
Metadata
- Authors
- Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., ESC Scientific Document Group, Filippatos, G., McMurray, J. J. V., Aboyans, V., Achenbach, S., Agewall, S., Al-Attar, N., Atherton, J. J., Bauersachs, J., John Camm, A., Carerj, S., Ceconi, C., Coca, A., Elliott, P., Erol, Ç., Ezekowitz, J., Fernández-Golfín, C., Fitzsimons, D., Guazzi, M., Guenoun, M., Hasenfuss, G., Hindricks, G., Hoes, A. W., Iung, B., Jaarsma, T., Kirchhof, P., Knuuti, J., Kolh, P., Konstantinides, S., Lainscak, M., Lancellotti, P., Lip, G. Y. H., Maisano, F., Mueller, C., Petrie, M. C., Piepoli, M. F., Priori, S. G., Torbicki, A., Tsutsui, H., van Veldhuisen, D. J., Windecker, S., Yancy, C., Zamorano, J. L., Zamorano, J. L., Aboyans, V., Achenbach, S., Agewall, S., Badimon, L., Barón-Esquivias, G., Baumgartner, H., Bax, J. J., Bueno, H., Carerj, S., Dean, V., Erol, Ç., Fitzsimons, D., Gaemperli, O., Kirchhof, P., Kolh, P., Lancellotti, P., Lip, G. Y. H., Nihoyannopoulos, P., Piepoli, M. F., Ponikowski, P., Roffi, M., Torbicki, A., Vaz Carneiro, A., Windecker, S., Sisakian, H. S., Isayev, E., Kurlianskaya, A., Mullens, W., Tokmakova, M., Agathangelou, P., Melenovsky, V., Wiggers, H., Hassanein, M., Uuetoa, T., Lommi, J., Kostovska, E. S., Juillière, Y., Aladashvili, A., Luchner, A., Chrysohoou, C., Nyolczas, N., Thorgeirsson, G., Marc Weinstein, J., Di Lenarda, A., Aidargaliyeva, N., Bajraktari, G., Beishenkulov, M., Kamzola, G., Abdel-Massih, T., Celutkiene, J., Noppe, S., Cassar, A., Vataman, E., Abir-Khalil, S., van Pol, P., Mo, R., Straburzynska-Migaj, E., Fonseca, C., Chioncel, O., Shlyakhto, E., Otasevic, P., Goncalvesová, E., Lainscak, M., Díaz Molina, B., Schaufelberger, M., Suter, T., Yilmaz, M. B., Voronkov, L., & Davies, C.
- Affiliations
- University Medical Center Groningen (NL)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-20
- Volume
- 37
- Issue
- 27
- Pages
- 2129-2200
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2397911846
- Cited by
- 11,429
- References
- 635
- Citations by year
- 2026: 266 · 2025: 574 · 2024: 713 · 2023: 821 · 2022: 1320 · 2021: 2191 · 2020: 1892 · 2019: 1462 · 2018: 1172 · 2017: 830 · 2016: 179
- FWCI
- 1001.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- European Heart Journal (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- American Heart Association
- American College of Cardiology Foundation
- National Institute for Health and Care Research (NF-SI-0611-10227)
- Parkinson's UK (G-0907)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- heart failure, acute heart failure, chronic heart failure, diagnosis, treatment
- MeSH terms
- Healthy Lifestyle, Acute Disease, Algorithms, Angina Pectoris, Arthritis, Cardiotonic Agents, Central Nervous System Diseases, Chronic Disease, Coronary Disease, Echocardiography, Electrocardiography, Exercise Therapy, Genetic Testing, Heart Failure, Heart Valve Diseases, Humans, Hypercalcemia, Hyperlipidemias, Hypertension, Hypokalemia, Erectile Dysfunction, Kidney Diseases, Lung Diseases, Male, Myocardial Revascularization, Neoplasms, Terminology as Topic, Obesity, Physical Examination, Prognosis, Sleep Wake Disorders, Stroke Volume, Biomarkers, Heart Transplantation, Ventricular Dysfunction, Anemia, Iron-Deficiency, Evidence-Based Medicine, Diabetes Complications, Cardiac Imaging Techniques, Cardiac Resynchronization Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
